SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-19-006137
Filing Date
2019-09-26
Accepted
2019-09-26 07:20:20
Documents
5
Period of Report
2019-09-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_092519.htm 8-K 14763
2 PRESS RELEASE exh_101.htm EX-10.1 1026
3 PRESS RELEASE exh_991.htm EX-99.1 6402
4 exh101_01.jpg GRAPHIC 250474
5 exh101_02.jpg GRAPHIC 84144
  Complete submission text file 0001171843-19-006137.txt   483466
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 191115537
SIC: 2836 Biological Products, (No Diagnostic Substances)